These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6094787)

  • 1. Interaction of quaternary phenothiazine salts with calmodulin.
    Prozialeck WC
    J Pharmacol Exp Ther; 1984 Dec; 231(3):473-9. PubMed ID: 6094787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of beta-endorphin and other opioid peptides with calmodulin.
    Sellinger-Barnette M; Weiss B
    Mol Pharmacol; 1982 Jan; 21(1):86-91. PubMed ID: 6290868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin antagonistic action of new 1,5-benzothiazepines derived from diltiazem.
    Suzuki T; Ohashi M; Takaiti O; Harigaya S
    Arzneimittelforschung; 1994 Jan; 44(1):3-6. PubMed ID: 8135875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzo [b]-promazines, chlorpromazine free radical and analino-N, N-dimethylpropylamine analogs influence rat striatal DA-adenylate cyclase and calmodulin-phosphodiesterase.
    Sweatt JD; Palmer GC; Palmer SJ; Jackson TG; Manian AA
    Arch Int Pharmacodyn Ther; 1982 Jun; 257(2):188-99. PubMed ID: 6287952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of calmodulin in parathyroid adenomas.
    Oldham SB; Lipson LG; Tietjen GE
    Miner Electrolyte Metab; 1982; 7(5):273-80. PubMed ID: 6302460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of activity of chlorpromazine and respective hydroxy, dimethoxy and sulphoxide analogues on dopamine, muscarinic, histamine and calmodulin sites of action.
    Palmer GC; Blosser JC; McCreedy SA; Barrantes MA; Manian AA
    Xenobiotica; 1988 Mar; 18(3):277-89. PubMed ID: 2837873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides].
    Tkachuk VA; Men'shikov MIu
    Biokhimiia; 1981 Jun; 46(6):963-73. PubMed ID: 6266519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships.
    Prozialeck WC; Weiss B
    J Pharmacol Exp Ther; 1982 Sep; 222(3):509-16. PubMed ID: 6286920
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle.
    Luchowski EM; Yousif F; Triggle DJ; Maurer SC; Sarmiento JG; Janis RA
    J Pharmacol Exp Ther; 1984 Sep; 230(3):607-13. PubMed ID: 6433001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding.
    Williams JP; McDonald JM; McKenna MA; Jordan SE; Radding W; Blair HC
    J Cell Biochem; 1997 Sep; 66(3):358-69. PubMed ID: 9257192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume-regulated anion conductance in cultured rat cerebral astrocytes requires calmodulin activity.
    Olson JE; Li GZ; Wang L; Lu L
    Glia; 2004 May; 46(4):391-401. PubMed ID: 15095369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of alpha 2-macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamides.
    DiPaola M; Keith CH; Feldman D; Tycko B; Maxfield FR
    J Cell Physiol; 1984 Feb; 118(2):193-202. PubMed ID: 6319437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists.
    Hait WN; Lee GL
    Biochem Pharmacol; 1985 Nov; 34(22):3973-8. PubMed ID: 4062971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.
    Thayer SA; Fairhurst AS
    Mol Pharmacol; 1983 Jul; 24(1):6-9. PubMed ID: 6865927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity.
    Carfagna MA; Muhoberac BB
    Mol Pharmacol; 1993 Jul; 44(1):129-41. PubMed ID: 8393517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium ion dependent covalent modification of calmodulin with norchlorpromazine isothiocyanate.
    Newton DL; Burke TR; Rice KC; Klee CB
    Biochemistry; 1983 Nov; 22(24):5472-6. PubMed ID: 6317020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins.
    Marshak DR; Lukas TJ; Watterson DM
    Biochemistry; 1985 Jan; 24(1):144-50. PubMed ID: 2986673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical study of the binding of phenothiazine derivatives to residues 82-93 of calmodulin.
    Gresh N; Pullman B
    Mol Pharmacol; 1986 Apr; 29(4):355-62. PubMed ID: 3702854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Yamakado T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-demethylation of phenothiazines by lipoxygenase from soybean and human term placenta in the presence of hydrogen peroxide.
    Rajadhyaksha AV; Reddy V; Hover CG; Kulkarni AP
    Teratog Carcinog Mutagen; 1999; 19(3):211-22. PubMed ID: 10379845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.